Positive regulation of EMT, manifested as down-regulation of epithelial markers (e.g. E-cadherin) and up-regulation of mesenchymal markers (e.g. vimentin), by knockdown of ZFAS1 has been demonstrated in glioma, colorectal cancer and gastric cancer. Here, ZFAS1 is linked to glioma.